Beverage brands still searching for the right solution to their drink problem

9th September 2021 - Blogs , News analysis |

CBD beverages continue to be a popular niche sub-category for producers, with brands still experimenting and bringing out new variations. Some significant regulatory concerns remain for the mid/long-term. Neither the US, UK or EU has explicitly permitted CBD to be used as an ingredient for a beverage or any other ingestible product. And there is growing concern that – given » Continue Reading.

Italian company gains EU validation for synthetic CBD novel food application

8th July 2021 - News analysis |

The European Commission (EC) has validated a novel food application submitted by the Italian company Farmabios for a synthetic CBD. This is the first step to gaining novel food authorisation from the European Food Safety Authority (EFSA). The company said it had also submitted a similar dossier to the UK Food Standards Agency (FSA) and expects to receive validation there » Continue Reading.

Why is crowd-funding an increasingly popular option for CBD companies to raise investment?

21st June 2021 - Blogs |

Nordic Oil’s announcement of a crowd-funding launch on Seedrs is the latest in a growing queue of crowd-funding announcements. There are several reasons why even large CBD brands are increasingly turning towards crowd-funding as a method for raising funds. The most obvious is that it remains difficult for them to agree terms with more traditional funders. Banks and even government » Continue Reading.

Is delta-8 THC a legal product in the US?

20th May 2021 - Blogs |

CBD-Intel’s opinion from a reading of laws at the federal level is that – currently – delta-8 THC should be considered legal if derived from a legal hemp plant. This is because the federal definition of hemp encompasses multiple parts including cannabinoids, derivatives and isomers and shields them from the federal definition of tetrahydrocannabinols listed in Schedule I of the » Continue Reading.

What can we learn from the distribution of brands by main product category and retailer type in the UK?

14th May 2021 - Blogs |

CBD-Intel’s new UK online report highlights a number of interesting market developments. Among them is the information that brand distribution provides. From a dominance perspective, more brands are now being listed for cosmetic than vape products. This shows how cosmetics now have more exposure to the wider population by having a more diverse range of brand offerings along with greater » Continue Reading.

Could CBD/hemp vaping equipment be exempt from the incoming rule prohibiting the mailing of e-cigarette and vaporiser-related products through the US Postal Service (USPS)?

7th May 2021 - Blogs |

Recent consultation guidance does suggest that the USPS is considering broadly exempting hemp and CBD services from the incoming rule. The guidance states: “For hemp-based products containing CBD with a THC concentration not exceeding 0.3 percent, mailers must retain, and prepare to make available upon request, records establishing compliance with all applicable federal, state, and local laws pertaining to hemp » Continue Reading.

What is the state of science behind minor cannabinoids really like?

29th April 2021 - Blogs |

Minor cannabinoids are gaining increasing interest – pushed by both slowly growing consumer awareness and companies looking to develop further revenue streams from under-utilised products. A number of claims have been made about the properties of various minor cannabinoids – some skirting dangerously close to the line of what is currently permitted and some going well over that health claims » Continue Reading.

How fast is the UK Food Standards Agency (FSA) novel food application validation process moving?

22nd April 2021 - Blogs |

It does not look like good news. The only two companies (controlling three brands that contain 23 individually listed products) included in the initial list of validated applications both say they submitted their applications to the FSA in early January. Both also are at least partly based on synthetic CBD ingredients that have successfully navigated EU novel food application initial » Continue Reading.

Is delta-8 THC really the next big thing?

14th April 2021 - Blogs |

From a consumer/market perspective, it certainly looks like delta-8 THC is the most promising minor cannabinoid. It has quickly overtaken others such as CBG and CBN in terms of general awareness and – anecdotally – in terms of interest from companies and consumers alike. The appeal appears to be that it acts as a “lighter” version of delta-9 THC – the more typical psychoactive element » Continue Reading.

Now that the deadline for applications has passed, when should enforcement action from the UK Food Standards Agency (FSA) be expected?

1st April 2021 - Blogs |

The FSA told CBD-Intel during a recent conference that – unsurprisingly – no actions would be taken until after the list of validated/administratively checked pending validation applications had been published. Thus far no date for the publication of the list has been put forward, but the speculation is that it will now more than likely be at least May before it » Continue Reading.

Was the UK FSA decision to make changes to the novel food application timeline really that unexpected?

25th March 2021 - Blogs |

The UK Food Standards Agency (FSA) has ruffled a few feathers by changing its criteria for allowing products to stay on the market. Instead of requiring a validated novel food submission, it now only requires a submission that has been administratively checked (essentially scanned over to make sure all required bits are present) – under the assumption that the application » Continue Reading.

Will the FSA-validated novel food submission list reveal commercially sensitive information?

11th March 2021 - Blogs |

There’s been some worry that the eventual list of brands with a novel food application validated by the UK Food Standards Agency (FSA) will reveal commercially sensitive information such as which brands are currently contracted to which ingredient or white-label goods suppliers. But the FSA has not indicated that such information would be included in any list. And there is » Continue Reading.